Novavax-Serum Institute Vaccine Gets Emergency Use Approval In Indonesia

Biotechnology firm Novavax Inc and its partner Serum Institute of India on Monday said they have received the first emergency use authorisation (EUA) for Novavax''s COVID-19 vaccine, in Indonesia.

from NDTV News - Special https://ift.tt/3jWRVMd